Articles related to COVID-19

Neurologic manifestations of long COVID affect approximately 30% of patients regardless of vaccination status or initial disease severity, presenting significant implications for workforce productivity and healthcare delivery.

Advanced molecular screening methods for colorectal cancer and AI-assisted colonoscopy detection systems represent significant developments in diagnostic technology, potentially improving both accuracy and accessibility of cancer screening programs.

The discovery of I-NCMs’ ability to simultaneously patrol blood vessels and infiltrate tumor environments opens new possibilities for treating therapy-resistant cancers.

Healthcare facilities across multiple California counties face varying mask requirements, highlighting the continued regional approach to respiratory virus prevention in medical settings.

The updated COVID-19 vaccines generate a more pronounced and specific immune response against current circulating strains, potentially reducing infection rates and, crucially, severe disease.

The FDA’s approval of new COVID-19 vaccines targeting the KP.2 strain comes amidst concerns about waning immunity and evolving virus variants.